12.07.2015 Views

marker-assisted selection in wheat - ictsd

marker-assisted selection in wheat - ictsd

marker-assisted selection in wheat - ictsd

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chapter 21 – Marker-<strong>assisted</strong> <strong>selection</strong> as a potential tool for genetic improvement: debat<strong>in</strong>g the issues 439was a scarcity of private animal breed<strong>in</strong>g<strong>in</strong>itiatives <strong>in</strong> develop<strong>in</strong>g countries andlittle or no commercial sector. MAS, <strong>in</strong> hisop<strong>in</strong>ion, would not change this situation.Nicol (19) highlighted the importance ofextension agencies <strong>in</strong> assist<strong>in</strong>g uptake ofcommercially available DNA <strong>marker</strong> tests.Koudandé (68) noted that <strong>in</strong> developedcountries, most of the applied MAS<strong>in</strong> breed<strong>in</strong>g is undertaken by companies,and wondered which companies <strong>in</strong> Africawould be wealthy enough to support MASdevelopment and application. An additionalfactor is that MAS requires that molecular<strong>marker</strong>s are available for particular cropsand important traits, but most of the publiclyavailable <strong>marker</strong>s are for the majorcrops (Collard, 9), which are not necessarilyof primary importance <strong>in</strong> develop<strong>in</strong>gcountries. Some crops are also very regionspecific, such as black gram mentioned byGopalakrishna (72), and are unlikely to bethe target of research lead<strong>in</strong>g to developmentof MAS technologies. There seemedto be general support for a collaborativeapproach to MAS research and application,<strong>in</strong>clud<strong>in</strong>g public–private sector l<strong>in</strong>kages,which would represent the best opportunityto facilitate development of, andaccess to, MAS <strong>in</strong> develop<strong>in</strong>g countries.Unfortunately, private sector contributionsto this e-mail conference were limited andthe discussion would have benefited from<strong>in</strong>puts by more of them.ReferencesThe author, number and title of messages referenced <strong>in</strong> the chapter – all messages areavailable at www.fao.org/biotech/logs/c10logs.htmAcikgoz, N. (66). Is MAS a little luxurious fordevelop<strong>in</strong>g countries?Badr, A. (47). Tropical fruit breed<strong>in</strong>gBhagwat, A. (46). Polyploid cropsBhatia, C.R. (8). Indicators of utility of MAS <strong>in</strong>plant breed<strong>in</strong>gBuijs, J. (22). MAS and other ongo<strong>in</strong>g researchBuijs, J. (58). Locally adapted technologyChávez, J. (33). MAS and animal breed<strong>in</strong>gCollard, B. (9). Cost of MAS - the biggestbarrierCollard, B. (45). Investment makes MAS feasible<strong>in</strong> developed countriesCorva, P. (29). Use of licensed genomictechnologyDavila, A. (81). MAS and bio<strong>in</strong>formatics fordevelop<strong>in</strong>g countriesDe Kon<strong>in</strong>g, D-J. (13). MAS for livestock <strong>in</strong>develop<strong>in</strong>g countriesDe Kon<strong>in</strong>g, D-J. (16). Re: Cross<strong>in</strong>g-over //false-positive <strong>marker</strong>sDe Kon<strong>in</strong>g, D-J. (20). Re: MAS for livestock <strong>in</strong>develop<strong>in</strong>g countriesDe Lange, W. (57). Experiences with MAS so far- Netherlands, plantsDulieu, H.L. (23). Genetic conditions for MASefficiencyDulieu, H.L. (42). Re: When the <strong>marker</strong> is thegeneDulieu, H.L. (53). Re: <strong>marker</strong> <strong>assisted</strong>backcross<strong>in</strong>gEl Ouafi, I. (77). Some of the ma<strong>in</strong> topics fordiscussionFairbanks, D. (60). Collaborative <strong>in</strong>ternationalresearch on MASFasoula, D. (84). Re: Integration of molecular<strong>marker</strong>s with plant breed<strong>in</strong>gGalvez, H. (10). MAS for tree crop improvementand transgenicsGalvez, H. (38). Re: When the <strong>marker</strong> is thegeneGanunga, R. (69). Flank<strong>in</strong>g <strong>marker</strong>s/ Patent<strong>in</strong>g

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!